Advancing
Medicine with
Precision®
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases.
Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
Next
Generation
Therapies
Our disciplined design approach uses non-viral and viral expression systems, genome, DNA, RNA and protein engineering, and a suite of precision bioengineering switch technologies controlling gene expression and regulation to deliver potent on-target gene and cell therapies with improved safety and efficacy.
Every minute counts
18 Lives Lost
Every Minute¹
1,000 Lives Lost
Every Hour¹
26,000+ Lives Lost
Each Day¹
800,000 Lives Lost
Each Month¹
We are driven by this urgency. Each minute is an opportunity to make a difference.
12018 World Health Organization International Agency for Research on Cancer (IARC) Cancer Fact Sheet.
Calculated from the WHO IARC global mortality statistic in the 2018 Cancer Fact Sheet
Cancer is responsible for an estimated 9.6 million deaths in 2018.
Join our team
Learn MoreIf you yearn for a career where you work with dedicated, smart people and what you do makes a meaningful impact on science, medicine, and patients, join our team. We are passionate about our people and seek to hire the best.
Precigen is an equal opportunity employer.